Royal Bank of Canada’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-9,135
| Closed | -$83K | – | 8144 |
|
|
2021
Q2 | $83K | Buy |
9,135
+2,795
| +44% | +$16.3K | ﹤0.01% | 5732 |
|
|
2021
Q1 | $31K | Buy |
6,340
+4,028
| +174% | +$19.5K | ﹤0.01% | 6192 |
|
|
2020
Q4 | $10K | Buy |
2,312
+2,048
| +776% | +$8.33K | ﹤0.01% | 6402 |
|
|
2020
Q3 | $1K | Buy |
264
+11
| +4% | +$46 | ﹤0.01% | 6537 |
|
|
2020
Q2 | $1K | Sell |
253
-111
| -30% | -$496 | ﹤0.01% | 6551 |
|
|
2020
Q1 | $1K | Sell |
364
-2,652
| -88% | -$22.5K | ﹤0.01% | 6569 |
|
|
2019
Q4 | $26K | Buy |
3,016
+2,816
| +1,408% | +$22K | ﹤0.01% | 5751 |
|
|
2019
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 6593 |
|
|
2019
Q2 | $2K | Sell |
200
-38
| -16% | -$328 | ﹤0.01% | 6636 |
|
|
2019
Q1 | $2K | Buy |
238
+38
| +19% | +$386 | ﹤0.01% | 6579 |
|
|
2018
Q4 | $2K | Sell |
200
-5,793
| -97% | -$73K | ﹤0.01% | 6507 |
|
|
2018
Q3 | $84K | Sell |
5,993
-2,046
| -25% | -$27.7K | ﹤0.01% | 4954 |
|
|
2018
Q2 | $85K | Buy |
8,039
+8,031
| +100,388% | +$78.3K | ﹤0.01% | 4892 |
|
|
2018
Q1 | $0 | Buy |
+8
| New | +$70 | ﹤0.01% | 7001 |
|
|
2017
Q4 | – | Sell |
-2,022
| Closed | -$16K | – | 7077 |
|
|
2017
Q3 | $16K | Buy |
2,022
+1,905
| +1,628% | +$14.3K | ﹤0.01% | 6085 |
|
|
2017
Q2 | $1K | Buy |
117
+110
| +1,571% | +$789 | ﹤0.01% | 6471 |
|
|
2017
Q1 | $0 | Buy |
+7
| New | +$44 | ﹤0.01% | 6915 |
|
|
2015
Q4 | – | Sell |
-673
| Closed | -$3K | – | 6922 |
|
|
2015
Q3 | $3K | Sell |
673
-30
| -4% | -$185 | ﹤0.01% | 6325 |
|
|
2015
Q2 | $4K | Buy |
703
+53
| +8% | +$376 | ﹤0.01% | 6286 |
|
|
2015
Q1 | $5K | Sell |
650
-500
| -43% | -$3.45K | ﹤0.01% | 5754 |
|
|
2014
Q4 | $9K | Buy |
1,150
+175
| +18% | +$1.48K | ﹤0.01% | 5655 |
|
|
2014
Q3 | $9K | Sell |
975
-1,050
| -52% | -$14.2K | ﹤0.01% | 5518 |
|
|
2014
Q2 | $38K | Buy |
+2,025
| New | +$34.4K | ﹤0.01% | 4980 |
|
Other funds holding KIN
Royal Bank of Canada's KIN Position: Q3 2021 in Review
Royal Bank of Canada sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 9,135 shares — an estimated $83K sold.
Royal Bank of Canada first reported a position in KIN in Q2 2014 and held it in 23 quarters. The position peaked at $85K in Q2 2018. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- Royal Bank of Canada reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Royal Bank of Canada sold 9,135 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $83K.
- Royal Bank of Canada first reported a position in Kindred Biosciences, Inc. in Q2 2014 and held it in 23 quarters.
- Royal Bank of Canada's Kindred Biosciences, Inc. position peaked at $85K in Q2 2018.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on Royal Bank of Canada's 13F filing for Q3 2021, filed 15 Nov 2021.